MD – POLY

`
INTRODUCTION

Compositions: Collagen, Drosera, NaCl, water for injection

Dosage Form: Injectable Solution

Packaging: Box 10 vials (single vial 2 ml – Extraction volumn).

Uses:

 

MD-POLY is a medical device designed to help movement,
specifically the vertebral spine. Its main therapeutic functions include:
1. A barrier effect.
2. A lubricating action.
3. Mechanical support while administering other pharmacological treatments.

MD-POLY may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.
When a supportive treatment is needed for the connective tissue matrix or when an antiaging action is necessary, MD-POLY can be used together with MD-MATRIX and MD-TISSUE.
It may also be used as mechanical support while treating the following
diseases:
• Small joints rheumatoid arthritis of hand and foot (in association with MD-SMALL JOINTS).
• Non-specific diffuse pain (in association with MD-NECK and MD-NEURAL).
• Costo-sternal syndrome (in association with MD-NEURAL).
• Chronic polyarthritis due to auto-immune diseases (e.g. Lupus erithematosus sistemicus) (in association with MD-NEURAL when nerve pain is dominant; in association with MD-MUSCLE when
muscle pain is dominant).
• Breakbone fever (when nerve pain is dominant in association with MD-NEURAL; when muscle pain is dominant in association with MD-MUSCLE).
• Joint pain due to viral or protozoic disease (in association with another Guna medical device containing the same type of collagen contained in the joint to be treated).
• Joint pain due to cancer (chronic leukaemia, multiple myeloma) (in
association with another Guna medical device containing the same type of collagen contained in the joint to be treated).

Directions for use
Therapeutic protocol:
1-2 treatments weekly for 10 consecutive weeks.
Periarticular injection technique (the site of application must be aseptic; insert the
needle at a 3-6 mm depth)
For this purpose the use of the following materials and accessories is
recommended:
• Materials for aseptic skin preparation: single-use gloves, iodine
solution, alcohol solution, sterile gauze pads, ethyl chloride spray
for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to
inject.
Intraarticular injection technique
For this purpose the use of the following materials and accessories is
recommended:
• Materials for aseptic skin preparation: single-use gloves, iodine
solution, alcohol solution, sterile gauze pads, ethyl chloride spray
for the skin.
The application of a topical anaesthetic on the skin area to be treated
is recommended.
• Needles: sterile 22 G.
• Syringes: 5 or 10 cc size, according to the volume of the solution to
inject.
Contraindications / Side effects
There is no history of hypersensitivity to MD-POLY. However,
patients with known hypersensitivity to any ingredient or excipient
should be tested before use, making a spot injection into one arm and
be monitored for 1 hour.

Instructions in case of damage to the sterile vials
Do not use if the seal is broken or if the vial is not perfectly sealed.
Once open, the content of the vial must be immediately injected. Do
not use if the package is damaged.

Thành phần

Collagen, Drosera, NaCl, water for injection

USES

MD-POLY is a medical device designed to help movement,
specifically the vertebral spine. Its main therapeutic functions include:
1. A barrier effect.
2. A lubricating action.
3. Mechanical support while administering other pharmacological treatments.

MD-POLY may be used as a single treatment or mixed with other medical devices of the same range, in order to make a customised treatment according to clinical evolution.
When a supportive treatment is needed for the connective tissue matrix or when an antiaging action is necessary, MD-POLY can be used together with MD-MATRIX and MD-TISSUE.
It may also be used as mechanical support while treating the following
diseases:
• Small joints rheumatoid arthritis of hand and foot (in association with MD-SMALL JOINTS).
• Non-specific diffuse pain (in association with MD-NECK and MD-NEURAL).
• Costo-sternal syndrome (in association with MD-NEURAL).
• Chronic polyarthritis due to auto-immune diseases (e.g. Lupus erithematosus sistemicus) (in association with MD-NEURAL when nerve pain is dominant; in association with MD-MUSCLE when
muscle pain is dominant).
• Breakbone fever (when nerve pain is dominant in association with MD-NEURAL; when muscle pain is dominant in association with MD-MUSCLE).
• Joint pain due to viral or protozoic disease (in association with another Guna medical device containing the same type of collagen contained in the joint to be treated).
• Joint pain due to cancer (chronic leukaemia, multiple myeloma) (in
association with another Guna medical device containing the same type of collagen contained in the joint to be treated).